retatrutide approved in other countries ESC 2024: improves lipid and cardiovascular risk profile Phase II trial Retatrutide and the Grey Market:

Tirzepatide for adults living with obesity

The newest weight-loss drug, called retatrutide, could help people lose 30% of body weight, based on recent clinical trials

In a trial, investigators set dose groups to answer research questions

Eligibility is determined by a medical professional based on your BMI and any weight-related health conditions

Contact: Emily Passer [email protected] Data & methodology Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)

Table 1 Dietary modifications for the management of postbariatric hypoglycemia